Fiera Capital (Canada)’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,927,230
Closed -$164M 685
2020
Q3
$164M Sell
1,927,230
-762,234
-28% -$38.5M 0.49% 46
2020
Q2
$95.3M Sell
2,689,464
-54,939
-2% -$1.61M 0.32% 53
2020
Q1
$37M Sell
2,744,403
-105,669
-4% -$1.78M 0.15% 89
2019
Q4
$60.3M Buy
2,850,072
+669,388
+31% +$11.8M 0.2% 76
2019
Q3
$28.9M Sell
2,180,684
-27,542
-1% -$405K 0.11% 136
2019
Q2
$30.6M Buy
2,208,226
+136,173
+7% +$2.05M 0.12% 138
2019
Q1
$39.8M Buy
+2,072,053
New +$33.4M 0.16% 120

Fiera Capital (Canada)'s IMMU Position: Q4 2020 in Review

Fiera Capital (Canada) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,927,230 shares — an estimated $164M sold.

Fiera Capital (Canada) first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $164M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Fiera Capital (Canada) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,927,230 Immunomedics Inc shares in Q4 2020, an estimated $164M.
  • Fiera Capital (Canada) first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
  • Fiera Capital (Canada)'s Immunomedics Inc position peaked at $164M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2020, filed 9 Feb 2021.